CULVER CITY, Calif.--(BUSINESS WIRE)--May 3, 2017--
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based,
personalized healthcare company, announced today that the company will
present at the Deutsche Bank 42nd Annual Health Care Conference at 10:40
a.m. ET, on Thursday, May 4, 2017 at the InterContinental Boston Hotel.
The company also said that Robert Watson, who will present on behalf of
NantHealth at the Deutsche conference, is transitioning from his role as
president and chief growth officer to consultant for the company, in
order to relocate to the East Coast for family reasons.
“In his transitional role, Bob will remain an important member of our
team through the end of the year,” said Patrick Soon-Shiong, M.D., Chief
Executive Officer and Chairman of NantHealth. “Bob oversaw the
integration of several acquisitions and was instrumental in leading our
company’s transition from a private to public company.”
“I am very grateful for the time I spent at NantHealth and to have
launched the initial public offering,” said Watson. “I am a firm
believer in the immense value GPS cancer will bring to the thousands of
cancer patients who will benefit from the information derived from this
breakthrough test. I am confident that NantHealth will continue as a
leading evidence-based personalized healthcare company in the years
The company will post to its website the slides presented at the
Deutsche Bank 42nd Annual Health Care Conference.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth's unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissues and integrates
this molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, which includes its unique
software, middleware and hardware systems infrastructure that collects,
indexes, analyzes and interprets billions of molecular, clinical,
operational and financial data points derived from novel and traditional
sources, continuously improves decision-making and further optimizes our
clinical pathways and decision algorithms over time. For more
information please visit www.nanthealth.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170503006827/en/
Source: NantHealth, Inc.
for NantHealth, Inc.